An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus in Participants Who Are Co-Infected With Human Immunodeficiency Virus:C-EDGE CO-INFXN (MK-5172-061)
Clinical trial NCT02105662 · COMPLETED
Trial details
- NCT number
- NCT02105662
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-03
- Primary completion
- 2015-02-20
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.